SCHEMBL26550279

SCHEMBL26550279

COc1ccncc1NC(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC1 P19801 2/20 0.53
▸ AOC3 Q16853 2/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ LMNA P02545 3/20 0.44
▸ PTGS1 P23219 2/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ MAPT P10636 3/20 0.39
▸ MITF O75030 1/20 0.39
▸ TRPM8 Q7Z2W7 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2E1 P05181 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21621161 0.85 AOC1 (0.49) AOC1AOC3SMN1; SMN2LMNAPTGS1
SCHEMBL4483021 0.79 AOC1 (0.48) AOC1AOC3SMN1; SMN2LMNAPTGS1
SCHEMBL14995307 0.77 CA12 (0.49) AOC1AOC3SMN1; SMN2LMNAPTGS1
SCHEMBL19766580 0.75 AOC1 (0.58) AOC1AOC3LMNAPTGS1MAPT
SCHEMBL18934401 0.73 AOC1 (0.56) AOC1AOC3SMN1; SMN2PTGS1MAPT
SCHEMBL9274896 0.73 L3MBTL1 (0.38) PTGS1CA12CA1CA2CA9
SCHEMBL1644887 0.72 ALDH1A1 (0.50) SMN1; SMN2LMNACA12CA1CA2
SCHEMBL6120121 0.71 PTGS1 (0.69) PTGS1CA12CA1CA2CA9
SCHEMBL21540857 0.71 AOC1 (0.53) AOC1AOC3LMNAPTGS1PTGS2
SCHEMBL10216217 0.71 CA1 (0.46) SMN1; SMN2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 — — WO disclosed
Send feedback